Novel Affibody Molecules Specifically Bind to SARS-CoV-2 Spike Protein and Efficiently Neutralize Delta and Omicron Variants-Reference-Cited by-同舟云学术

Novel Affibody Molecules Specifically Bind to SARS-CoV-2 Spike Protein and Efficiently Neutralize Delta and Omicron Variants

Published:2023-02-14 Issue:1 Volume:11 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Du Wangqi¹^ORCID,Jiang Peipei¹²,Li Qingfeng¹,Wen He¹,Zheng Maolin¹,Zhang Jing¹,Guo Yanru¹,Yang Jia¹,Feng Weixu¹,Ye Sisi²,Kamara Saidu¹,Jiang Pengfei¹,Chen Jun¹,Li Wenshu¹,Zhu Shanli¹,Zhang Lifang¹^ORCID

Affiliation:

1. Institute of Molecular Virology and Immunology, Department of Microbiology and Immunology, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China

2. The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China

Abstract

SARS-CoV-2 and its variants are threatening the whole world. Although a full dose of vaccine injection showed great preventive effects and monoclonal antibody reagents have also been used for a specific treatment, the global pandemic persists.

Funder

Wenzhou Medical University

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/spectrum.03562-22

Reference64 articles.

1. Effectiveness of COVID-19 diagnosis and management tools: A review

2. rRT-PCR for SARS-CoV-2: Analytical considerations

3. COVID-19 in the environment

4. SARS-CoV-2: Targeted managements and vaccine development

5. Balasundaram P, Morgan-Joseph T. 2022. Etesevimab, StatPearls. StatPearls Publishing LLC., Treasure Island, FL.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances of affibody molecules in biomedical applications;Bioorganic & Medicinal Chemistry;2024-11

2. Structure‐based computational design of antibody mimetics: challenges and perspectives;FEBS Open Bio;2024-06-26

3. Design of targeted antiviral polypeptides specific to SARS-CoV-2. Challenges and prospects;Russian Chemical Reviews;2024-06

4. Dendritic Cell‐Mediated Cross‐Priming by a Bispecific Neutralizing Antibody Boosts Cytotoxic T Cell Responses and Protects Mice against SARS‐CoV‐2;Advanced Science;2023-10-20